SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-015639
Filing Date
2020-08-14
Accepted
2020-08-14 06:12:05
Documents
48
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 392832
2 ex31-1.htm EX-31.1 8043
3 ex31-2.htm EX-31.2 7977
4 ex32-1.htm EX-32.1 4850
5 ex32-2.htm EX-32.2 4879
  Complete submission text file 0001493152-20-015639.txt   2277396

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cytr-20200630.xml EX-101.INS 328681
7 XBRL CALCULATION FILE cytr-20200630_cal.xml EX-101.CAL 42853
8 XBRL DEFINITION FILE cytr-20200630_def.xml EX-101.DEF 96506
9 XBRL LABEL FILE cytr-20200630_lab.xml EX-101.LAB 232909
10 XBRL PRESENTATION FILE cytr-20200630_pre.xml EX-101.PRE 165885
11 XBRL SCHEMA FILE cytr-20200630.xsd EX-101.SCH 31181
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
CYTRX CORP (Filer) CIK: 0000799698 (see all company filings)

IRS No.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15327 | Film No.: 201101211
SIC: 2836 Biological Products, (No Diagnostic Substances)